Related Experiment Video
Updated: May 4, 2026
05:00
Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction
Published on: April 1, 2019
14.8K
Emerging treatment options for meibomian gland dysfunction.
1Department of Ophthalmology, Peking University First Hospital, Key Laboratory of vision Loss and Restoration, Ministry of Education, Beijing, People's Republic of China.
Clinical Ophthalmology (Auckland, N.Z.)
|September 18, 2013
Summary
Meibomian gland dysfunction (MGD), a common cause of dry eye, presents treatment challenges. Emerging therapies offer new hope for managing MGD symptoms and improving ocular surface health.
Area of Science:
- Ophthalmology
- Dry Eye Disease Research
Background:
- Meibomian gland dysfunction (MGD) is a prevalent condition and the primary cause of evaporative dry eye.
- Current treatments like warm compresses, lid hygiene, antibiotics, and anti-inflammatories have limitations.
- Despite various therapeutic options, complete relief from MGD signs and symptoms remains challenging.
Purpose of the Study:
- To review emerging treatment options for Meibomian gland dysfunction (MGD).
- To provide an overview of novel therapies addressing the complexities of MGD management.
Main Methods:
- Literature review of current and emerging MGD treatments.
- Focus on therapies including intraductal probing, lipid emulsion eye drops, thermal pulsation, N-acetyl-cysteine, azithromycin, omega-3 fatty acids, and cyclosporine A.
Main Results:
- Emerging treatments show promise in addressing MGD.
- Novel approaches target meibum obstruction and gland function directly.
- A range of options are available, from mechanical interventions to pharmacological agents.
Conclusions:
- New therapeutic strategies are expanding the MGD treatment landscape.
- These emerging options may offer improved outcomes for patients with MGD.
- Further research is needed to fully establish the efficacy and long-term benefits of these novel treatments.
Related Concept Videos
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.9K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.9K
01:20Myasthenia Gravis: Overview and Treatment
3.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:28Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
01:23Ophthalmic Drug Delivery Systems
283
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
283
01:22Microbiome of the Eye
67
The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
67